Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Shares Outstanding (Diluted Average): 2020-2024

Historic Shares Outstanding (Diluted Average) for vTv Therapeutics (VTVT) over the last 5 years, with Dec 2024 value amounting to $5.8 million.

  • vTv Therapeutics' Shares Outstanding (Diluted Average) rose 46.51% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 46.51%. This contributed to the annual value of $5.8 million for FY2024, which is 176.79% up from last year.
  • vTv Therapeutics' Shares Outstanding (Diluted Average) amounted to $5.8 million in FY2024, which was up 176.79% from $2.1 million recorded in FY2023.
  • vTv Therapeutics' Shares Outstanding (Diluted Average)'s 5-year high stood at $47.1 million during FY2020, with a 5-year trough of $1.6 million in FY2021.
  • For the 3-year period, vTv Therapeutics' Shares Outstanding (Diluted Average) averaged around $3.3 million, with its median value being $2.1 million (2023).
  • In the last 5 years, vTv Therapeutics' Shares Outstanding (Diluted Average) plummeted by 96.68% in 2021 and then soared by 176.79% in 2024.
  • Yearly analysis of 5 years shows vTv Therapeutics' Shares Outstanding (Diluted Average) stood at $47.1 million in 2020, then slumped by 96.68% to $1.6 million in 2021, then grew by 22.58% to $1.9 million in 2022, then rose by 8.60% to $2.1 million in 2023, then surged by 176.79% to $5.8 million in 2024.